Close Menu

NEW YORK – The US Food and Drug Administration announced Thursday that South Korean molecular diagnostic firm GeneMatrix received Emergency Use Authorization for its SARS-CoV-2 molecular test. 

The company's NeoPlex COVID-19 Detection Kit uses RT-PCR to detect SARS-CoV-2 nucleic acid from upper and lower respiratory specimens, including nasal swabs, sputum, and tracheal aspirates.

The test can be performed by high-complexity CLIA-certified laboratories.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.